CardioMech
Norway - TrondheimMedical Devices
Focus: CardioMech is a medical device company focused on catheter-based therapies for cardiovascular disease, headquartered in Trondheim, Norway and founded in 2018. The company is early-stage with limited public visibility on employee count and funding.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About CardioMech
AI assessmentNot HiringNo open roles listed right now. Follow CardioMech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CardioMech MVRS
Mitral RegurgitationClinical Trials (1)
NCT04820764EFS of the CardioMech MVRS
N/AHelp build intelligence for CardioMech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.